Abstract
Keywords
Ado-Trastuzumab (293)ADR Reporting (285)Anticonvulsants (288)Antiplatelet Agents (280)Aspirin (281)Atorvastatin (270)Bedaquiline (286)Bevacizumab (284)Bisphosphonates (297)Clozapine (296)Dietary Supplement (277,283)Drugs (289,290,295)Estrogens (292)Herbal Supplement (287)Hydralazine (275)Infliximab (272)Isotretinoin (271)Ivermectin (274)JAK Inhibitors (282)Kedaling Tablets (273)Methadone (279)Pembrolizumab (276)Prednisolone (291)Propranolol (294)Tofacitinib (278)Zoster Vaccine (298)
Get full access to this article
View all access options for this article.